Survival in Women Diagnosed With Breast Cancer During Pregnancy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Introduction: Pregnancy rarely coincides with breast cancer, but when it does, uncertainties remain about how survival is affected. In a nation-wide study, we investigated survival in women diagnosed with breast cancer during pregnancy. Materials and Methods: Through health registries, we identified women with breast cancer at ages 15-44 years from 1973-2016 in Denmark and included 156 who were pregnant at diagnosis and 11,110 who were not. We compared overall mortality in pregnant and non–pregnant women using multivariate Cox regression stratified by time since cancer: <2 and ≥2 years. Results: During the first 2 years after diagnosis, the hazard ratio of overall death was 2.28 (95% CI: 1.48-3.52) for pregnant versus non–pregnant breast cancer patients after adjustment for age and calendar period and 1.62 (95% CI: 1.05-2.50) after further adjustment for extent of disease. Adjusting for additional tumor characteristics, the hazard ratio was still significantly increased. Beyond the first 2 years, there was no excess mortality. Conclusion: Our study identifies the early period after breast cancer as a period of particular interest in future studies on survival after breast cancer in pregnancy. We found no evidence that survival is affected by pregnancy when 2 or more years have passed since diagnosis.

OriginalsprogEngelsk
TidsskriftClinical Breast Cancer
Vol/bind22
Udgave nummer4
Sider (fra-til)e517-e525
Antal sider9
ISSN1526-8209
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
Maj-Britt Jensen reports institutional grants from NanoString Technologies, Oncology Venture and Samsung Bioepis. Bent Ejlertsen reports grants to his institution from NanoString Technologies, AstraZeneca, Novartis, Oncology Venture, Pfizer, Roche, and Samsung. The other authors declare no conflict of interest.

Funding Information:
The Novo Nordisk Foundation (grant number NNF18OC0052571 ) and Helsefonden (grant number 20-B-0350 ) supported this work. The founders had no role in either the design, data collection, analysis, interpretation, writing or the submission of the study.

Publisher Copyright:
© 2021 Elsevier Inc.

ID: 314149007